Effect of porcine circovirus type 2 vaccination of sows on selected production parameters

• Autorzy: Pejsak Z , Truszczynski M. , Porowski M. , Podgorska K.
• Języki publikacji: EN

Abstrakty

EN

An aim of the study was to evaluate the efficacy of Circovac vaccine in two Polish pig herds affected by post-weaning multisystemic wasting syndrome (PMWS) and reproductive failure. The effectiveness of vaccination was assessed indirectly by analysis of production performance of the examined herds. It was found that Circovac is extremely efficient in reducing losses attributed to PMWS and controlling the disease. Analysis of production parameters after vaccination showed significant improvement in the nursery and finishing sectors. Post-weaning mortality dropped nearly five times in herd P and 2.5 times in herd D. Mortality among fatteners decreased by half in both herds. Additionally, significant improvement was observed concerning average daily weight gains of weaners and fatteners. Despite the considerable benefits of vaccination in nursery and finishing pigs, a tendency to increase reproductive parameters was observed. The most striking differences concerned returns to oestrus and abortion rates, which reached more favourable levels even compared to the period before the PMWS episode. This observation suggests that subclinical infections with PCV2 may have negative effects on the reproduction.

Słowa kluczowe

EN

pig; porcine circovirus type 2; sow; vaccination; Circovag vaccine; reproductive failure; production parameter; post-weaning multisystemic wasting syndrome

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2009
• Tom: 53
• Numer: 2
• Opis fizyczny: p.159-164,ref.

Twórcy

autor

Pejsak Z

• National Veterinary Research Institute, 24-100 Pulawy, Poland

autor

Truszczynski M.

autor

Porowski M.

autor

Podgorska K.

Bibliografia

• 1. Bielanski A., Larochelle R., Algire J., Magar R.: Distribution of PCV-2 DNA in the reproductive tract, oocytes and embryos of PCV-2 antibody-positive pigs. Vet Rec 2004, 155, 597-598.
• 2. Brunborg I.M., Jonassen C.M., Moldal T., Bratberg B., Lium B., Koenen F., Schonheit J.: Association of myocarditis with high viral load of porcine circovirus type 2 in several tissues in cases of fetal death and high mortality in piglets. A case study. J Vet Diagn Invest 2007, 19, 368-375.
• 3. Calsamiglia M., Fraile L., Espinal A., Cuxart A., Seminati C., Martin M., Mateu E., Domingo M., Segales J.: Sow porcine circovirus type 2 (PCV2) status effect on litter mortality in postweaning multisystemic wasting syndrome (PMWS). Res Vet Sci 2007, 82, 299-304.
• 4. Cariolet R., Blanchard P., Le Dimna M., Mahe D., Keranflech A., Julou P., Beaurepaire B., de Boisseson C., Truong C., Jestin A.: Consequences of PCV2 experimental infection of non-immune SPF sows using the intra-uterine route. Proceedings of the Congress on ssDNA viruses of plants, birds, pigs and primates. Saint- Malo, France, 2001, p. 129.
• 5. Delisle C., Delisle G., Bridoux N., Thibault J.C., Longo S., Joisel F.: PCV2 vaccination of sows with Circovac® (Mérial) in France: improvement of the weaning-to- slaughter performance of their progeny. Proceedings of the 20th IPVS Congress, Durban, South Africa, 2008, 2, p. 77.
• 6. Ebbesen T., Kunstmann L.: Effect of sow vacciantion with Circovac® on stillborn piglets. Proceedings of the 20th IPVS Congress, Durban, South Africa, 2008, 2, p. 81.
• 7. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segales J.: Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 8, 1063-1071.
• 8. Herin J.B., Fily B., Longo S., Joisel F.: Field results of the use of Circovac® a sow PCV2 vaccine in France under provisional license. Proceedings of the 5th International Symposium on Emerging and Re-emerging Pig Diseases, Kraków, Poland, 2007, p. 125.
• 9. Johnson C.S., Joo H.S., Direksin K., Yoon K.J., Choi Y.K.: Experimental in utero inoculation of late-term swine fetuses with porcine circovirus type 2. J Vet Diagn Invest 2002, 14, 507-512.
• 10. Joisel F., Brune A., Schade A., Longo S., Charreyre C.: Improvement of reproduction performance induced by PCV2 vaccination of sows and gilts with Circovac® in 277 German sow farms. Proceedings of the 20th IPVS Congress, Durban, South Africa, 2008, 2, p. 72.
• 11. Joisel F., Brune A., Schade A., Longo S., Charreyre C.: Results of the vaccination against PCV2 diseases with Circovac® in 233 German sow herds: decrease in mortality. Proceedings of the 5th International Symposium on Emerging and Re-emerging Pig Diseases, Kraków, Poland, 2007, p. 126.
• 12. Josephson G., Charbonneau G.: What's your interpretation? Case report of reproductive problem in a new startup operation. JSHAP 2001, 9, 258-259.
• 13. King D., Dubois P., Painter T., Holck T., Edler R., Johnson C., Diaz E.: Biologic and economic benefits of controlling subclinical PCVAD with PCV2 vaccination. Proceedings of the 20th IPVS Congress, Durban, South Africa, 2008, 2, p. 36.
• 14. Kixmoller M., Ritzmann M., Eddicks M., Saalmuller A., Elbers K., Fachinger V.: Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26, 3443-3451.
• 15. Kunstmann L., Lau L.: Effect of sow vaccination with Circovac® on the performance of 34 Danish herds. Proceedings of the 20th IPVS Congress, Durban, South Africa, 2008, 2, p. 75.
• 16. Lefebvre D.J., Van Reeth K., Vangroenweghe F., Castryck F., Maes D., Laitat M., Nauwynck H.J.: Serosurvey for viruses associated with reproductive failure in newly introduced gilts and in muciparous sows in Belgian sow herds. Proceedings of the 20th IPVS, Durban, South Africa, 2008, 1, p. 93.
• 17. Mateusen B., Maes D.G., Van Soom A., Lefebvre D., Nauwynck H.J.: Effect of a porcine circovirus type 2 infection on embryos during early pregnancy. Theriogenology 2007, 68, 896-901.
• 18. O'Connor B., Gauvreau H., West K., Bogdan J., Ayroud M., Clark E.G., Konoby C., Allan G., Ellis J.A.: Multiple porcine circovirus 2-associated abortions and reproductive failure in a multisite swine production unit. Can Vet J 2001, 42, 551-553.
• 19. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G.: Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27, 1002-1007.
• 20. Park J.S., Kim J., Ha Y., Jung K., Choi C., Lim J.K., Kim S.H., Chae C.: Birth abnormalities in pregnant sows infected intranasally with porcine circovirus 2. J Comp Pathol 2005, 132, 139-144.
• 21. Pejsak Z., Podgórska K., Szczotka A., Kozaczyński W., Stadejek T.: Occurrence of PMWS in Polish farms reporting episodes of wasting in weaned pigs. Proceedings of the 5th International Symposium on Emerging and Re-emerging Pig Diseases, Kraków, Poland, 2007, p. 88
• 22. Sanchez R.E., Jr., Nauwynck H.J., McNeilly F., Allan G.M., Pensaert M.B.: Porcine circovirus 2 infection in swine foetuses inoculated at different stages of gestation. Vet Microbiol 2001, 83, 169-176.
• 23. Schoning T., Nielsen P., Lau L.: Effect of Circovac® (Mérial) on porcine circovirus type 2 (PCV2) sow reproductive failure and mortality: a case report Proceedings of the 20th IPVS Congress, Durban, South Africa, 2008, 2, p. 108.
• 24. Segales J., Allan G.M., Domingo M.: Porcine circovirus diseases. Anim Health Res Rev 2005, 6, 119-142.
• 25. Sorden S.: Update on porcine circovirus and postweaning multisystemic wasting syndrome (PMWS). Swine Health Prod 2000, 8, 133-136.
• 26. Stadejek T.: Zespół wyniszczenia poodsadzeniowego (PMWS) świń - możliwości zwalczania. Lecznica Dużych Zwierząt 2006, 1, 14-18.
• 27. Stadejek T., Podgórska K., Kołodziejczyk P., Bogusz R., Kozaczyński W., Pejsak Z.: First report of postweaning multisystemic wasting syndrome in pigs in Poland. Medycyna Wet 2006, 62, 297-301.
• 28. Stadejek T., Porowski M., Podgórska K., Jabłoński A., Pejsak Z.: Concurrent outbreak and control of PRRS and PMWS in a swine farm in Poland. Proceedings of the 5th International Symposium on Emerging and Re-emerging Pig Diseases, Kraków, Poland, 2007, p. 110.
• 29. Truszczyński M., Pejsak Z.: Pathogenicity of circoviruses with particular reference to post-weaning multisystemic wasting syndrome of swine. Medycyna Wet 2008, 64, 379-382.
• 30. Waddilove J.: Benefits of sow vaccination against complex PCVD in a finishing herd. Proceedings of the 20th IPVS Congress, Durban, South Africa, 2008, 2, p. 104.
• 31. Yoon K.J., Jepsen R.J., Pogranichniy R.M., Sorden S., Stammer R., Evans L.E.: A novel approach to intrauterine viral inoculation of swine using PCV type 2 as a model. Theriogenology 2004, 61, 1025-1037.
• 32. Young M., Cunningham G., Sanford E.: Performance of Ingelvac Circoflex® vaccinated pigs in a subclinical PCVAD herd. Proceedings of the 20th Congress IPVS, Durban, South Africa, 2008, 1, p. 25.